Latest article
U.S. FDA declines to approve Provention Bio’s diabetes drug
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
‘Much less ingesting lowers diabetes sufferers’ heart problems dangers’
A research team at Seoul National University Hospital (SNUH) found that type 2 diabetes patients can reduce their risk of atrial fibrillation by drinking...